1. Home
  2. ETD vs PHAR Comparison

ETD vs PHAR Comparison

Compare ETD & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ethan Allen Interiors Inc.

ETD

Ethan Allen Interiors Inc.

HOLD

Current Price

$23.58

Market Cap

610.5M

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$16.31

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ETD
PHAR
Founded
1932
1988
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
610.5M
1.1B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
ETD
PHAR
Price
$23.58
$16.31
Analyst Decision
Hold
Strong Buy
Analyst Count
2
2
Target Price
$28.00
$38.00
AVG Volume (30 Days)
301.3K
22.5K
Earning Date
01-28-2026
11-06-2025
Dividend Yield
7.67%
N/A
EPS Growth
N/A
N/A
EPS
1.85
0.00
Revenue
$607,296,000.00
$362,274,000.00
Revenue This Year
N/A
$24.80
Revenue Next Year
$3.32
$6.84
P/E Ratio
$12.75
$2,946.57
Revenue Growth
N/A
26.78
52 Week Low
$21.67
$7.50
52 Week High
$32.61
$18.12

Technical Indicators

Market Signals
Indicator
ETD
PHAR
Relative Strength Index (RSI) 42.54 51.06
Support Level $23.83 $16.23
Resistance Level $24.46 $17.00
Average True Range (ATR) 0.56 0.75
MACD 0.05 -0.16
Stochastic Oscillator 5.52 36.44

Price Performance

Historical Comparison
ETD
PHAR

About ETD Ethan Allen Interiors Inc.

Ethan Allen Interiors Inc through its subsidiaries, operates as an interior design company, and a manufacturer and retailer in the home furnishings marketplace. Its product offerings include fabric chairs, beds, wallpapers, desks, and dining tables among others. The company's reportable segments are; Wholesale and Retail. The Wholesale segment is principally involved in the development of the Ethan Allen brand and encompasses all aspects of design, manufacturing, sourcing, marketing, sale, and distribution of home furnishings and accents. The Retail segment which generates maximum revenue, sells home furnishings and accents to clients through company-operated design centers. Geographically, it derives key revenue from the United States and the rest from other regions.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: